Announcements Trials

Browse Landscape

Status

Active not recruiting 3 Unknown 1 Recruiting 1 Completed 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 5 Neoplasms 4 Ovarian Neoplasms 2 Motor Activity 2 Fallopian Tube Neoplasms 2 Uncertainty 1 Polyps 1 Pancreatic Neoplasms 1 Palliative Care 1 Pain 1 Obesity 1 Neoplasm Metastasis 1 Lung Neoplasms 1 Knee Tumor 1 Inflammation 1 Head and Neck Neoplasms 1 Depression 1 Critical Illness 1 Colorectal Neoplasms 1 Colonic Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Brenner Tumor 1 Breast Carcinoma In Situ 1 Breast Cancer Lymphedema 1 Adenoma 1

Interventions

Fluorouracil 19 Oxaliplatin 17 Capecitabine 16 Leucovorin 14 Cisplatin 12 Irinotecan 11 Gemcitabine 11 Drug Therapy 11 Bevacizumab 10 Radiosurgery 9 Cetuximab 9 pembrolizumab 8 Docetaxel 8 Everolimus 7 spartalizumab 6 Sunitinib 6 Radiotherapy 6 Paclitaxel 6 Neoadjuvant Therapy 6 Trastuzumab 5 S 1 (combination) 5 Nivolumab 5 Immunotherapy 5 Immune Checkpoint Inhibitors 5 Cyclophosphamide 5 Chemotherapy, Adjuvant 5 Carboplatin 5 palbociclib 4 manganese chloride 4 Surgical Procedures, Operative 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Neoplasm Metastasis × Methods × Clear all

NCT02251353 2020-02-21

IMET

Federation of Breast Diseases Societies

Breast Neoplasms, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡